Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is a long-term condition that needs more research for better understanding and treatment.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Age, gender, and hair loss affect scalp characteristics differently in young Caucasian adults.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

Hair follicles and deer antlers regenerate similarly through stem cells and are influenced by hormones and growth factors.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

Women with telogen effluvium have lower levels of iron, folate, and vitamin B12.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

The Rotterdam Study aims to understand various diseases in older adults.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Tributyltin exposure causes sex changes, sterilization, and decline in the snail Ocinebrina aciculata, risking its extinction.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

The unit area trichogram is a reliable method to assess hair loss and treatment response in people with androgenic alopecia by measuring hair density and thickness.

Women with thinning hair have thinner hair strands than women without hair loss.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Beard cells, unlike scalp cells, produce growth factors in response to testosterone, which may explain differences in hair growth.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.